%0 Journal Article
%A Schlenk, R. F.
%A Weber, D.
%A Herr, W.
%A Wulf, G.
%A Salih, H. R.
%A Derigs, H. G.
%A Kuendgen, A.
%A Ringhoffer, M.
%A Hertenstein, B.
%A Martens, U. M.
%A Grießhammer, M.
%A Bernhard, H.
%A Krauter, J.
%A Girschikofsky, M.
%A Wolf, D.
%A Lange, E.
%A Westermann, J.
%A Koller, E.
%A Kremers, S.
%A Wattad, M.
%A Heuser, M.
%A Thol, F.
%A Göhring, G.
%A Haase, D.
%A Teleanu, V.
%A Gaidzik, V.
%A Benner, A.
%A Döhner, K.
%A Ganser, A.
%A Paschka, P.
%A Döhner, H.
%T Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.
%J Leukemia
%V 33
%N 8
%@ 1476-5551
%C London
%I Springer Nature
%M DKFZ-2019-02050
%P 1923 - 1933
%D 2019
%X Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:30728457
%R 10.1038/s41375-019-0395-y
%U https://inrepo02.dkfz.de/record/144608